Sullivan Ryan T Insider Trades

Insider Trading History

Track insider trading activity for Sullivan Ryan T. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $469k 24,708 shares
Last Trade
Nov 13, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.7k 493 shares
$37.87
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $479k 25,201 shares
Last Trade
Aug 13, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$25.6k 493 shares
$51.86
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $488k 25,694 shares
Last Trade
May 13, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$41.9k 493 shares
$85.08
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $498k 26,187 shares
Last Trade
Feb 13, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$46.7k 493 shares
$94.69
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $507k 26,680 shares
Last Trade
Jan 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$917k 9,200 shares
$99.66
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $401k 21,080 shares
Last Trade
Dec 31, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$100k 809 shares
$123.92
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $503k 26,475 shares
Last Trade
Nov 19, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$712k 8,325 shares
$85.55
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $489k 25,718 shares
Last Trade
Nov 19, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.03M 12,154 shares
$85.00
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $647k 34,043 shares
Last Trade
Nov 19, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$712k 8,325 shares
$85.55
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $661k 34,800 shares
Last Trade
Nov 13, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42k 500 shares
$83.92
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $489k 25,718 shares
Last Trade
Nov 13, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$59.7k 711 shares
$83.92
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $502k 26,429 shares
Last Trade
Nov 13, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$42.5k 500 shares
$85.00
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $512k 26,929 shares
Last Trade
Nov 13, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42k 500 shares
$83.92
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $502k 26,429 shares
Last Trade
Aug 13, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$45.5k 689 shares
$66.03
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $515k 27,118 shares
Last Trade
May 13, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$59.5k 711 shares
$83.73
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $529k 27,829 shares
Last Trade
Feb 13, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$217k 1,971 shares
$110.35
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel And Secretary
Holding Value $566k 29,800 shares
Last Trade
Jan 16, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.92M 17,300 shares
$110.80
$19.00
Intercept Pharmaceuticals
Intercept Pharmaceuticals ICPT
General Counsel
Holding Value $671k 35,300 shares
Last Trade
Feb 13, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.12M 58,500 shares
$53.41
$19.00
Arctos NorthStar Acquisition
Arctos NorthStar Acquisition ANAC
EVP And General Counsel
Holding Value $0 0 shares
Last Trade
Jun 24, 2016 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
No data
No data
$10.19
Arctos NorthStar Acquisition
Arctos NorthStar Acquisition ANAC
EVP And General Counsel
Holding Value $307k 30,132 shares
Last Trade
Apr 29, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$10.19

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up